GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.520
+0.020 (0.80%)
May 19, 2026, 4:00 PM EDT - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Prescription Transactions Revenue
508.77M544.00M577.55M
Prescription Transactions Revenue Growth
-6.48%-5.81%4.87%
Subscription Revenue
87.16M83.79M86.54M
Subscription Revenue Growth
4.03%-3.18%-8.34%
Pharma Manufacturer Solutions Revenue
174.96M151.38M107.24M
Pharma Manufacturer Solutions Revenue Growth
15.58%41.16%26.06%
Other Service Revenue
17.00M17.69M21.00M
Other Service Revenue Growth
-3.91%-15.79%4.74%
Total Other Service Revenue
191.96M169.07M128.24M
Total Other Service Revenue Growth
13.54%31.84%22.00%
Revenue (Total)
787.89M796.85M792.32M
Revenue (Total) Growth
-1.13%0.57%5.61%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Monthly Active Consumers
5.30M5.30M6.60M
Monthly Active Consumers Growth
--19.70%3.13%
Subscription Plans
717.00K674.00K684.00K
Subscription Plans Growth
6.38%-1.46%-22.62%
Updated May 6, 2026. Data Source: Fiscal.ai.